Integrating Deep Learning with Biology: A New Frontier in Triple-Negative Breast Cancer Treatment Prediction?

References

• 1. Hu Y, Wang C, Liang H, Li J, Yang Q. The treatment landscape of triple-negative breast cancer. Med Oncol 2024;41(10):236.
  Medline Google Scholar
• 2. Wu C, Jarrett AM, Zhou Z, et al. MRI-based digital models forecast patient-specific treatment responses to neoadjuvant chemotherapy in triple-negative breast cancer. Cancer Res 2022;82(18):3394–3404.
  Medline Google Scholar
• 3. Spring LM, Fell G, Arfe A, et al. Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis. Clin Cancer Res 2020;26(12):2838–2848.
  Medline Google Scholar
• 4. Azizi E, Carr AJ, Plitas G, et al. Single-cell map of diverse immune phenotypes in the breast tumor microenvironment. Cell 2018;174(5):1293–1308.e36.
  Medline Google Scholar
• 5. Gullo RL, Partridge SC, Shin HJ, Thakur SB, Pinker K. Update on DWI for Breast Cancer Diagnosis and Treatment Monitoring. AJR Am J Roentgenol 2024;222(1):e2329933.
  Medline Google Scholar
• 6. Mohammad Mirzaei N, Su S, Sofia D, et al. A mathematical model of breast tumor progression based on immune infiltration. J Pers Med 2021;11(10):1031.
  Medline Google Scholar
• 7. Guo J, Chen B, Cao H, et al. Cross-modal deep learning model for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer. npj Precis Onc 2024;8(189).
  Google Scholar
• 8. Stowers CE, Wu C, Xu Z, et al. Combining biology-based and MRI data-driven modeling to predict response to neoadjuvant chemotherapy in patients with triple-negative breast cancer. Radiol Artif Intell 2025;7(1):e240124.
  Google Scholar
• 9. Ronneberger O, Fischer P, Brox T. U-Net: Convolutional Networks for Biomedical Image Segmentation. In: Navab N, Hornegger J, Wells W, Frangi A, eds. Medical Image Computing and Computer-Assisted Intervention – MICCAI 2015. MICCAI 2015. Lecture Notes in Computer Science, vol 9351. Springer, 2015; 234–241.
  Google Scholar
• 10. Surov A, Wienke A, Meyer HJ. Pretreatment apparent diffusion coefficient does not predict therapy response to neoadjuvant chemotherapy in breast cancer. Breast 2020;53:59–67.
  Medline Google Scholar